What is Suvoda?
Suvoda is an innovative SaaS company dedicated to transforming clinical trials through advanced technology. Its Interactive Response Technology (IRT) system is designed to address complex patient randomization and clinical trial supply chain challenges, enabling biopharmaceutical companies and clinical research organizations to focus on patient care. Suvoda IRT offers configurable features, powerful reporting, and advanced functionality to support intricate and novel study designs. Headquartered in Conshohocken, PA, Suvoda operates globally, providing comprehensive customer and advisory services.
How much funding has Suvoda raised?
Suvoda has raised a total of $40M across 1 funding round:
Private Equity
$40M
Private Equity (2019): $40M with participation from LLR
Key Investors in Suvoda
LLR
LLR Partners is a private equity firm focused on technology and healthcare businesses, known for collaborating with portfolio companies to drive growth and create long-term value through equity capital for growth, recapitalizations, and buyouts.
What's next for Suvoda?
The recent major strategic investment signals a pivotal phase for Suvoda, likely aimed at accelerating product development, expanding its global reach, and enhancing its service offerings. This capital infusion is expected to bolster its position in the competitive clinical trial technology market, enabling further innovation in IRT solutions and strengthening its partnerships with biopharmaceutical firms and CROs. Suvoda's focus on solving complex logistical challenges within clinical trials positions it for continued expansion and leadership.
See full Suvoda company page
